Middle East and Africa In-vitro Diagnostics Market Grew at a CAGR of 3.20% During the Period 2026-2035, Driven by Increasing Incidence of Lifestyle Diseases

In-vitro diagnostics (IVDs) assist clinical and personal decision making, though these do not directly drive health outcomes. In-vitro diagnostics are valuable resources for disease prevention, identification and management, and influence a significant amount of clinical decision making.

Healthcare trends in Saudi Arabia (represented by demographic shifts, high incidence rates of lifestyle related diseases, rising demand for private healthcare services, and strategic investments by the government) have driven demand for in vitro diagnostic (IVD) devices. The Middle East and Africa in-vitro diagnostics market is expected to witness growth with growing adoption of solutions and increasing investments in the sector by leading healthcare players.

For in-vitro diagnostics, the Middle East and African markets offer significant scope for growth. Key drivers are expected to be rising number of chronic disease patients and technological advances in the in-vitro diagnostics domain. In Africa, key driving factors are likely to be an increase in chronic and infectious disease population, technological advancements, an ageing populace and growth of point-of-care diagnostics; these factors are expected to boost the Middle East and Africa in-vitro diagnostics market.

Diagnosis drives patient, financial and health systems impact, and enables universal health coverage. However, proper diagnosis is an area of concern, particularly in primary healthcare settings in low- and middle-income countries. In such countries, a wide range of IVDs is available to test patients in the primary care setting where laboratories are scarce or not available.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Findings of the Report:

• Middle East and Africa in-vitro diagnostics market is expected to be driven by increasing incidence of lifestyle related diseases and demand for better medical care.
• Advanced solutions by leading companies are likely to boost market growth.

Market Analysis by Product and Service, Technology, Application, End Use, and Country:

• By product and service, the market is segmented into Reagents and Kits, Instruments, and Software and Services.
• By technology, the market is classified into Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Haematology, Microbiology, Blood Glucose Self Monitoring, Coagulation and Haemostasis, Urinalysis, and Others.
• By application, the market is divided into Infectious Diseases, Diabetes, Cardiology, Oncology, Autoimmune Diseases, Nephrology, and Others.
• By end use, the market is classified into Hospitals, Laboratories, Homecare, and Others.
• By country, the market is segmented into Saudi Arabia, United Arab Emirates, Nigeria, South Africa, and Others.

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790